LON:BVXP Bioventix (BVXP) Share Price, News & Analysis → Prepare for a Recession Unlike Any Other (From American Hartford Gold Group) (Ad) Free BVXP Stock Alerts GBX 3,995 -205.00 (-4.88%) (As of 10:37 AM ET) Add Compare Share Share Today's Range 3,935▼ 4,16950-Day Range 4,200▼ 4,75052-Week Range 3,402▼ 5,100Volume2,320 shsAverage Volume5,783 shsMarket Capitalization£208.54 millionP/E Ratio2,450.92Dividend Yield3.95%Price TargetN/A Stock AnalysisStock AnalysisChartCompetitorsDividendHeadlinesInsider TradesStock AnalysisChartCompetitorsDividendHeadlinesInsider Trades Get Bioventix alerts: Email Address Ad American Hartford Gold GroupPrepare for a Recession Unlike Any OtherDave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW.GET THE FREE GUIDE About Bioventix Stock (LON:BVXP)Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants. It also provides contract SMAs and recombinant services. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom.Read More BVXP Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BVXP Stock News HeadlinesMay 8, 2024 | morningstar.comOxford BioMedica PLC OXOMay 4, 2024 | finance.yahoo.comThose who invested in Bioventix (LON:BVXP) a year ago are up 18%April 7, 2024 | finance.yahoo.comDon't Race Out To Buy Bioventix PLC (LON:BVXP) Just Because It's Going Ex-DividendMarch 29, 2024 | ft.comInvestors’ Chronicle: Central Asia Metals, Bioventix, KingfisherMarch 28, 2024 | finance.yahoo.comBioventix's (LON:BVXP) Dividend Will Be £0.68March 4, 2024 | finance.yahoo.comHere's Why We Think Bioventix (LON:BVXP) Might Deserve Your Attention TodayFebruary 28, 2024 | wsj.comBioventix PLCJanuary 29, 2024 | finance.yahoo.comA Look At The Intrinsic Value Of Bioventix PLC (LON:BVXP)January 13, 2024 | uk.news.yahoo.comCES, Circle-ing back to IPOs and why we're over the moon about OvermoonJanuary 12, 2024 | finance.yahoo.comWith 62% ownership of the shares, Bioventix PLC (LON:BVXP) is heavily dominated by institutional ownersDecember 18, 2023 | finance.yahoo.comInvestor Optimism Abounds Bioventix PLC (LON:BVXP) But Growth Is LackingNovember 30, 2023 | theglobeandmail.comForget forecasting – here’s how investors can prosper in a turbulent marketNovember 30, 2023 | finance.yahoo.comIs Bioventix PLC's (LON:BVXP) Recent Stock Performance Influenced By Its Fundamentals In Any Way?November 28, 2023 | uk.finance.yahoo.comBioventix PLC (51B.SG)November 28, 2023 | uk.finance.yahoo.comBioventix PLC (51B.F)November 16, 2023 | finance.yahoo.comThe past three years for Bioventix (LON:BVXP) investors has not been profitableNovember 3, 2023 | ft.comInvestors’ Chronicle: Bioventix, Asos, Ultimate ProductsOctober 31, 2023 | finance.yahoo.comBioventix Full Year 2023 Earnings: EPS: UK£1.61 (vs UK£1.47 in FY 2022)September 30, 2023 | finance.yahoo.comBiVictriX Therapeutics Plc (BVX.L)September 26, 2023 | finance.yahoo.comIf EPS Growth Is Important To You, Bioventix (LON:BVXP) Presents An OpportunityAugust 5, 2023 | finance.yahoo.comWith 63% institutional ownership, Bioventix PLC (LON:BVXP) is a favorite amongst the big gunsMay 10, 2023 | finance.yahoo.comInvestors in Bioventix (LON:BVXP) have seen respectable returns of 76% over the past five yearsApril 19, 2023 | finance.yahoo.comDo Bioventix's (LON:BVXP) Earnings Warrant Your Attention?March 30, 2023 | finance.yahoo.comBioventix (LON:BVXP) Is Paying Out A Larger Dividend Than Last YearFebruary 26, 2023 | finance.yahoo.comBioventix PLC (LON:BVXP) is largely controlled by institutional shareholders who own 65% of the companySee More Headlines Receive BVXP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Bioventix and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/30/2020Ex-Dividend for 4/26 Dividend4/11/2024Dividend Payable4/26/2024Today6/10/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryCannabis Current SymbolLON:BVXP CUSIPN/A CIKN/A Webwww.bioventix.com Phone+44-1252-728001FaxN/AEmployees12Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX 1.63 Trailing P/E Ratio2,557.67 Forward P/E Ratio22.99 P/E GrowthN/ANet Income£8.67 million Net Margins63.73% Pretax MarginN/A Return on Equity79.14% Return on Assets54.07% Debt Debt-to-Equity RatioN/A Current Ratio7.04 Quick Ratio5.50 Sales & Book Value Annual Sales£13.60 million Price / Sales16.00 Cash FlowGBX 134.97 per share Price / Cash Flow30.89 Book ValueGBX 219 per share Price / Book19.04Miscellaneous Outstanding Shares5,220,000Free FloatN/AMarket Cap£217.62 million OptionableNot Optionable Beta0.37 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleGrowth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.Get This Free Report Key ExecutivesMr. Peter John Harrison MA (Age 66)CEO & Director Comp: $281.63kMr. Bruce Edward Heath Hiscock (Age 66)CFO & Director Comp: $95.99kKey CompetitorsErgomedLON:ERGOPureTech HealthLON:PRTCSilence TherapeuticsLON:SLNOxford BiomedicaLON:OXBHorizon Discovery Group plc (HZD.L)LON:HZDView All CompetitorsInsidersBruce HiscockBought 11 shares on 4/29/2024Total: £50,072.00 ($4,552.00/share)Peter John HarrisonSold 62,000 sharesTotal: £260.40 M ($4,200.00/share)Bruce HiscockBought 17 shares on 11/27/2023Total: £67,609.00 ($3,977.00/share)View All Insider Transactions BVXP Stock Analysis - Frequently Asked Questions How have BVXP shares performed in 2024? Bioventix's stock was trading at GBX 4,300 at the beginning of the year. Since then, BVXP stock has decreased by 7.1% and is now trading at GBX 3,995. View the best growth stocks for 2024 here. How were Bioventix's earnings last quarter? Bioventix PLC (LON:BVXP) released its quarterly earnings results on Monday, March, 30th. The biotechnology company reported $69.28 earnings per share (EPS) for the quarter. Bioventix had a net margin of 63.73% and a trailing twelve-month return on equity of 79.14%. How often does Bioventix pay dividends? What is the dividend yield for Bioventix? Bioventix declared a dividend on Monday, March 25th. Stockholders of record on Thursday, April 11th will be given a dividend of GBX 68 per share on Friday, April 26th. This represents a dividend yield of 1.48%. The ex-dividend date is Thursday, April 11th. The official announcement can be viewed at this link. Read our dividend analysis for BVXP. Is Bioventix a good dividend stock? Bioventix (LON:BVXP) pays an annual dividend of GBX 158 per share and currently has a dividend yield of 3.67%. The dividend payout ratio is 9,693.25%. Payout ratios above 75% are not desirable because they may not be sustainable. Read our dividend analysis for BVXP. What other stocks do shareholders of Bioventix own? Based on aggregate information from My MarketBeat watchlists, some companies that other Bioventix investors own include Lancashire (LRE), Allena Pharmaceuticals (ALNA), Ampliphi Biosciences (APHB), Entain PLC (GVC.L) (GVC), Arbutus Biopharma (ABUS), Aurora Cannabis (ACBFF), AcelRx Pharmaceuticals (ACRX), Aldeyra Therapeutics (ALDX), Apellis Pharmaceuticals (APLS). How do I buy shares of Bioventix? Shares of BVXP stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:BVXP) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredTrump convicted... now what?Unexpected Twist to Trump's Trial Most folks sense there's more to the Trump trial than meets the eye. B...Stansberry Research | SponsoredIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTime is Running Out - June 25th Deadline Approaching!Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRIL...Paradigm Press | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bioventix PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Bioventix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.